Results 131 to 140 of about 2,984 (199)

Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study. [PDF]

Antimicrob Agents Chemother
Groll AH, Danziger-Isakov L, Gefen A, Fraser CJ, Schulte JH, Bielorai B, Karras NA, Bueno D, Shaw PJ, Broyde N, Haber B, Gilbert CL, Patel M, McCrea JB, Badshah C.   +14 more
europepmc   +1 more source

New evidence in the management of CMV infection: impact on prophylaxis and treatment. [PDF]

Rev Esp Quimioter
Fortún J.
europepmc   +1 more source

Population pharmacokinetic analysis of letermovir in adult hematopoietic cell transplant recipients. [PDF]

Antimicrob Agents Chemother
Royston L, Kunz C, Tonoli D, Lescuyer P, Neofytos D, Gotta V.   +5 more
europepmc   +1 more source

Cytomegalovirus in HIV: A Modifiable Driver of Inflammation, Frailty, and Aging. [PDF]

Curr HIV/AIDS Rep
Cabello Ubeda A, Erlandson KM, Freeman ML, Letendre SL, Wanjalla CN, Koethe JR, Corley MJ, Hunt PW, Gianella S.   +8 more
europepmc   +1 more source

Maribavir for cytomegalovirus retinitis: A case series and review of the literature. [PDF]

AJO Int
Shughoury A, Emami S, Kaisari E, Kharouba R, Thomas AS, Goldstein DA, Janetos TM.   +6 more
europepmc   +1 more source

Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries. [PDF]

BMC Infect Dis
Prats JAGG, Farsi KA, Al-Khabori M, Al-Saadawi N, Alshemmari SH, Cherif H, Ibrahim D, Kaloyannidis P, Swaka RLSW.   +8 more
europepmc   +1 more source

Cytomegalovirus infections in thoracic organ transplant recipients: Updates on prevention, treatment, and immune monitoring. [PDF]

JHLT Open
Collis BJ, Heldman MR, Wolfe CR.
europepmc   +1 more source

Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation. [PDF]

Immunotherapy
Wang Y, Wu J, Huang X, Xiao Y.
europepmc   +1 more source

Cytomegalovirus infection post-hematopoietic stem cell transplantation: a real-world perspective on risk factors and clinical practice. [PDF]

Clin Transplant Res
Chiew XY, Goh JY, Rusli NS, Iyadorai T, Ab Rahman S, Rehiman SH, Gan GG, Ariffin H.   +7 more
europepmc   +1 more source

Assessing the significance of cytomegalovirus reactivation in recipients of allogeneic hematopoietic stem cell transplantation: a cohort study. [PDF]

Braz J Med Biol Res
Oliveira LP, Paton EJA, Giovanardi MF, Silva AFD, Tavares LG, Fernandes CG, Dias JO, Fabreti-Oliveira RA.   +7 more
europepmc   +1 more source